FR2425245A1 - Procede pour la preparation d'une composition injectable d'urokinase - Google Patents
Procede pour la preparation d'une composition injectable d'urokinaseInfo
- Publication number
- FR2425245A1 FR2425245A1 FR7911841A FR7911841A FR2425245A1 FR 2425245 A1 FR2425245 A1 FR 2425245A1 FR 7911841 A FR7911841 A FR 7911841A FR 7911841 A FR7911841 A FR 7911841A FR 2425245 A1 FR2425245 A1 FR 2425245A1
- Authority
- FR
- France
- Prior art keywords
- urokinase
- preparation
- injectable composition
- lyophilizing
- lyophilization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
ON PREPARE UNE COMPOSITION INJECTABLE D'UROKINASE STABLE PAR LA LYOPHILISATION DE L'UROKINASE. LE PROCEDE CONSISTE A LYOPHILISER UNE SOLUTION AQUEUSE CONTENANT DE L'UROKINASE, DE L'ALBUMINE DE SERUM HUMAIN ET UN OU PLUSIEURS COMPOSES AMINOACIDES CHOISIS PARMI LES AMINOACIDES POLAIRES ET LEURS SELS. L'UROKINASE EST LARGEMENT UTILISEE EN TANT QU'AGENT FIBRINOLYTIQUE DANS LE TRAITEMENT DE MALADIES THROMBOTIQUES; LA PREPARATION DE L'INVENTION CONTENANT DE L'ACIDE GLUTAMIQUE A EGALEMENT UNE PROPRIETE CARACTERISTIQUE EXCELLENTE EN CE QUI CONCERNE SON ACTIVITE THROMBOLYTIQUE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5682678A JPS54147916A (en) | 1978-05-12 | 1978-05-12 | Preparation of urokinase injection |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2425245A1 true FR2425245A1 (fr) | 1979-12-07 |
FR2425245B1 FR2425245B1 (fr) | 1983-03-11 |
Family
ID=13038173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7911841A Granted FR2425245A1 (fr) | 1978-05-12 | 1979-05-10 | Procede pour la preparation d'une composition injectable d'urokinase |
Country Status (10)
Country | Link |
---|---|
US (1) | US4244943A (fr) |
JP (1) | JPS54147916A (fr) |
CA (1) | CA1115206A (fr) |
CH (1) | CH641046A5 (fr) |
DE (1) | DE2917899A1 (fr) |
DK (1) | DK147812B (fr) |
FR (1) | FR2425245A1 (fr) |
GB (1) | GB2021412B (fr) |
IT (1) | IT7949032A0 (fr) |
SE (1) | SE7904118L (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5813521A (ja) * | 1981-07-16 | 1983-01-26 | Green Cross Corp:The | ミエロペルオキシダ−ゼの粉末製剤 |
US4350659A (en) * | 1981-07-30 | 1982-09-21 | Corning Glass Works | Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives |
JPS59139323A (ja) * | 1983-01-28 | 1984-08-10 | Green Cross Corp:The | ウロキナ−ゼ乾燥製剤 |
SU1128601A1 (ru) * | 1983-05-10 | 1985-07-15 | Всесоюзный кардиологический научный центр АМН СССР | Урокиназа,иммобилизированна на фибриногене |
JPS6051119A (ja) * | 1983-08-30 | 1985-03-22 | Green Cross Corp:The | ウロキナ−ゼ乾燥製剤 |
JPS61111684A (ja) * | 1984-11-05 | 1986-05-29 | Terumo Corp | 精製されたウロキナ−ゼ複合体の製造方法 |
JPS61124383A (ja) * | 1984-11-16 | 1986-06-12 | Unitika Ltd | 固定化線維素溶解活性酵素の安定化法 |
DE3586952T2 (de) * | 1985-01-14 | 1993-07-22 | Shiseido Co Ltd | Fibrinophiler urokinase-komplex und dessen herstellung. |
JPS61238732A (ja) * | 1985-04-16 | 1986-10-24 | Green Cross Corp:The | ウロキナーゼ前駆体乾燥製剤 |
CA1336585C (fr) * | 1985-04-16 | 1995-08-08 | Kazuo Morimoto | Methode de stabilisation du precurseur de l'urokinose et preparation contenant ce precurseur |
NZ217844A (en) * | 1985-10-11 | 1989-10-27 | Sumitomo Pharma | A sustained release pharmaceutical composition containing silicone elastomer and an albumin |
JP2708749B2 (ja) * | 1987-08-10 | 1998-02-04 | エーザイ株式会社 | 修飾型tPA含有注射用組成物 |
WO1990001334A1 (fr) * | 1988-08-05 | 1990-02-22 | Codon | Formules d'activateur du plasminogene a base d'aspartate |
US4980165A (en) * | 1989-01-27 | 1990-12-25 | Genetics Institute, Inc. | Pharmaceutical formulations of plasminogen activator proteins |
JPH02268681A (ja) * | 1989-04-07 | 1990-11-02 | Green Cross Corp:The | ウロキナーゼ前駆体の安定化方法及び乾燥製剤 |
DE69025934T2 (de) * | 1989-05-17 | 1996-09-19 | Res Corp Technologies Inc | Verfahren und zusammensetzung zur thrombosebehandlung beim säugetier |
CA2020148C (fr) * | 1989-06-30 | 1995-07-11 | Robert Angelo Mercuri | Graphite pur et souple, ultramince |
EP2236617A1 (fr) | 2009-03-31 | 2010-10-06 | Leukocare Ag | Procédés de stérilisation de terminal de compositions biofonctionnelles |
BR112012027361A2 (pt) | 2010-04-27 | 2021-04-27 | Scil Technology Gmbh | formulação mia/cd-rap estável. |
CN104906054B (zh) * | 2015-06-15 | 2017-08-25 | 武汉人福药业有限责任公司 | 一种尿激酶冻干剂的制备方法 |
CN111450052A (zh) * | 2020-04-22 | 2020-07-28 | 南京南大药业有限责任公司 | 一种尿激酶注射液制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE665076A (fr) * | 1963-12-23 | 1965-12-08 | ||
FR2209776A1 (fr) * | 1972-12-07 | 1974-07-05 | Ajinomoto Kk |
-
1978
- 1978-05-12 JP JP5682678A patent/JPS54147916A/ja active Pending
-
1979
- 1979-05-03 DE DE19792917899 patent/DE2917899A1/de not_active Withdrawn
- 1979-05-09 US US06/037,280 patent/US4244943A/en not_active Expired - Lifetime
- 1979-05-10 GB GB7916251A patent/GB2021412B/en not_active Expired
- 1979-05-10 CH CH438379A patent/CH641046A5/de not_active IP Right Cessation
- 1979-05-10 SE SE7904118A patent/SE7904118L/xx not_active Application Discontinuation
- 1979-05-10 FR FR7911841A patent/FR2425245A1/fr active Granted
- 1979-05-10 DK DK195079AA patent/DK147812B/da not_active Application Discontinuation
- 1979-05-11 CA CA327,420A patent/CA1115206A/fr not_active Expired
- 1979-05-11 IT IT7949032A patent/IT7949032A0/it unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE665076A (fr) * | 1963-12-23 | 1965-12-08 | ||
FR2209776A1 (fr) * | 1972-12-07 | 1974-07-05 | Ajinomoto Kk |
Also Published As
Publication number | Publication date |
---|---|
CA1115206A (fr) | 1981-12-29 |
SE7904118L (sv) | 1979-11-13 |
GB2021412B (en) | 1982-08-25 |
JPS54147916A (en) | 1979-11-19 |
DK147812B (da) | 1984-12-17 |
CH641046A5 (de) | 1984-02-15 |
GB2021412A (en) | 1979-12-05 |
IT7949032A0 (it) | 1979-05-11 |
US4244943A (en) | 1981-01-13 |
DE2917899A1 (de) | 1979-11-22 |
FR2425245B1 (fr) | 1983-03-11 |
DK195079A (da) | 1979-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2425245A1 (fr) | Procede pour la preparation d'une composition injectable d'urokinase | |
KR860000842B1 (ko) | 종양 괴사 인자의 안정화 방법 | |
FR2448900A1 (fr) | Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle | |
FR2442054A1 (fr) | Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant | |
MA21182A1 (fr) | Ester 2,3,5,6-tetrafluorobenzylique d'acide (+) 1r-trans-2,2-dimeghyl-3-(2,2 dichlorovinyl) -cyclopropane-carboxylique, son procede de preparation et composition insecticide le contenant. | |
RU93004764A (ru) | Амиды сульфамидо- и сульфамидокарбонилпиридин-2-карбоновых кислот, их пиридин-n-оксиды, способ их получения и их применение в качестве лекарственных препаратов | |
NO178687C (no) | Fremgangsmåte for fremstilling av forenlige, lagringsstabile erythropoietinpreparater | |
FR2601876B1 (fr) | Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique | |
FR2651497B1 (fr) | Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
DE04007657T1 (de) | Pharmazeutische Zusammensetzung aus fibrinolytischem Mittel | |
FR2506616A1 (fr) | Preparation de gamma-globuline pour injectio n intraveineuse et procede de fabrication, et agent therapeutique ainsi produit | |
ATE84716T1 (de) | 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten. | |
FR2484418B1 (fr) | Nouveaux derives d'acide isocyanurique, utiles notamment comme agents cytostatiques, et leur procede de preparation | |
FR2439016A1 (fr) | Solution stable d'erythromycine | |
FR2643223B1 (fr) | Nouvelles emulsions aqueuses concentrees, leur procede de preparation et leur application dans le domaine pesticide | |
DE69737202T2 (de) | Thrombolytische substanzen mit antithrombotische aktivität | |
DE3625090A1 (de) | Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung | |
BR9004693A (pt) | Solucao aquosa,processo para aumentar a concentracao de proteina de uma proteina em uma solucao aquosa,e composicao farmaceutica | |
FR2503149B1 (fr) | Esters de mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques | |
ATE58521T1 (de) | Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel. | |
FR2354097A1 (fr) | Composition therapeutique de derives thiazoliques et sa preparation | |
GB1480089A (en) | Diluent composition for biologically active materials | |
FR2355506A1 (fr) | Adjuvant d'immunotherapie contenant un glycolipide comme ingredient actif et son procede de preparation | |
FR2618439B1 (fr) | Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques | |
FI880027A (fi) | Antibakteriellt lyofiliserat preparat. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |